BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 16638414)

  • 1. Guillain-Barré syndrome-like presentation in borderline leprosy with type-2 reaction.
    Rai VM; Shenoi S; Rao SN
    Dermatol Online J; 2006 Feb; 12(2):21. PubMed ID: 16638414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Borderline lepromatous leprosy presenting as a single cutaneous plaque.
    Armour KS; Scolyer RA; Barnetson RS
    Australas J Dermatol; 2005 Aug; 46(3):181-3. PubMed ID: 16008652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rifampicin-induced erythema nodosum leprosum-like eruption in borderline lepromatous leprosy.
    Karthikeyan K; Thappa DM; Kadhiravan T
    Indian J Lepr; 2001; 73(2):167-9. PubMed ID: 11579653
    [No Abstract]   [Full Text] [Related]  

  • 4. Erythema nodosum leprosum necroticans in a child--an unusual manifestation.
    Pandhi D; Mehta S; Agrawal S; Singal A
    Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):122-6. PubMed ID: 16830655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genital involvement and type I reaction in childhood leprosy.
    Gupta R; Singal A; Pandhi D
    Lepr Rev; 2005 Sep; 76(3):253-7. PubMed ID: 16248212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Annular vesiculobullous eruptions in type 2 reaction in borderline lepromatous leprosy: a case report.
    Kar HK; Raina A; Sharma PK; Bhardwaj M
    Indian J Lepr; 2009; 81(4):205-8. PubMed ID: 20704077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immuno-allergic accidents with rifamipcin].
    Flageul B; Wagner L; Cottenot F
    Acta Leprol; 2001-2002; 12(2):71-8. PubMed ID: 12136739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two microbiological relapses in a patient with lepromatous leprosy.
    Chakma JK; Girdhar A; Natrajan M; Kumar A; Girdhar BK
    Lepr Rev; 2008 Sep; 79(3):331-4. PubMed ID: 19009984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative evaluation of immunotherapeutic efficacy of BCG and mw vaccines in patients of borderline lepromatous and lepromatous leprosy.
    Narang T; Kaur I; Kumar B; Radotra BD; Dogra S
    Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):105-14. PubMed ID: 16830653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occurrence and management of leprosy reaction in China in 2005.
    Shen J; Liu M; Zhou M; Wengzhong L
    Lepr Rev; 2009 Jun; 80(2):164-9. PubMed ID: 19743620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lepromatous leprosy treated with combined chemotherapy and immunotherapy (injection BCG): three case reports.
    Lakshmi C; Srinivas CR
    Int J Dermatol; 2014 Jan; 53(1):61-5. PubMed ID: 23675902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leprosy pseudoimbricata: an unusual presentation of steroid-modified borderline lepromatous leprosy.
    Kumar S; Mehta H; Aggarwal D; Chatterjee D; Narang T; Dogra S
    Int J Dermatol; 2020 Apr; 59(4):e124-e125. PubMed ID: 31957882
    [No Abstract]   [Full Text] [Related]  

  • 13. Type I reaction in a borderline leprosy case successfully treated with multidrug therapy and ofloxacin.
    Asz-Sigall D; López-García L; Neme-Yunes Y; Yuen-Palos R; Vega-Memije ME; Arenas R
    Int J Dermatol; 2008 Oct; 47(10):1084-6. PubMed ID: 18986365
    [No Abstract]   [Full Text] [Related]  

  • 14. Rate of decline in bacterial index in leprosy; observations after three different chemotherapeutic interventions.
    Ganapati R; Pai VV; Shroff HJ; Gandewar K
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):264-6. PubMed ID: 9251604
    [No Abstract]   [Full Text] [Related]  

  • 15. Interleukin-1 beta production by peripheral blood mononuclear cells from leprosy patients.
    Jayapal V; Bai GS; Lobo D; Thyagarajan SP
    Int J Lepr Other Mycobact Dis; 1993 Sep; 61(3):462-4. PubMed ID: 8228447
    [No Abstract]   [Full Text] [Related]  

  • 16. Guillain-Barre syndrome 1N leprosy patients.
    Kumar S
    Indian J Lepr; 2005; 77(2):162-8. PubMed ID: 16044816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trials of daily, long-term minocycline and rifampin or clarithromycin and rifampin in the treatment of borderline lepromatous and lepromatous leprosy.
    Rea TH
    Int J Lepr Other Mycobact Dis; 2000 Jun; 68(2):129-35. PubMed ID: 11036492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromoblastomycosis in a case of borderline lepromatous leprosy with recurrent type II lepra reaction.
    Apte G; Gedam JR; Poojary S; Nagpur NG; Pai VV; Ganapathi R
    Lepr Rev; 2011 Sep; 82(3):310-5. PubMed ID: 22125940
    [No Abstract]   [Full Text] [Related]  

  • 19. An unusual presentation of facial palsy in leprosy; a case report.
    Thompson K
    Int J Lepr Other Mycobact Dis; 1995 Dec; 63(4):567-9. PubMed ID: 8642221
    [No Abstract]   [Full Text] [Related]  

  • 20. Silent iritis in treated bacillary negative leprosy.
    Thompson K; Job CK
    Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):306-10. PubMed ID: 8862265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.